Bessemer Group Inc. Grows Stock Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Bessemer Group Inc. lifted its holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 2.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,283,216 shares of the company's stock after purchasing an additional 79,976 shares during the quarter. Bessemer Group Inc. owned about 1.25% of Ryan Specialty worth $210,651,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. JPMorgan Chase & Co. raised its stake in Ryan Specialty by 107.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company's stock worth $30,504,000 after acquiring an additional 238,064 shares during the last quarter. Bar Harbor Wealth Management raised its stake in shares of Ryan Specialty by 5.9% in the fourth quarter. Bar Harbor Wealth Management now owns 168,871 shares of the company's stock worth $10,835,000 after purchasing an additional 9,482 shares during the last quarter. Barclays PLC lifted its holdings in shares of Ryan Specialty by 1.1% during the third quarter. Barclays PLC now owns 1,641,743 shares of the company's stock worth $108,994,000 after purchasing an additional 17,267 shares during the period. Teachers Retirement System of The State of Kentucky boosted its position in Ryan Specialty by 51.5% in the third quarter. Teachers Retirement System of The State of Kentucky now owns 30,760 shares of the company's stock valued at $2,042,000 after buying an additional 10,460 shares during the last quarter. Finally, HighTower Advisors LLC increased its holdings in Ryan Specialty by 101.6% in the 3rd quarter. HighTower Advisors LLC now owns 39,969 shares of the company's stock worth $2,661,000 after buying an additional 20,139 shares during the period. 84.82% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Ryan Specialty news, EVP Brendan Martin Mulshine sold 30,000 shares of the firm's stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Nicholas Dominic Cortezi sold 35,000 shares of the company's stock in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $65.99, for a total value of $2,309,650.00. Following the completion of the sale, the director now owns 35,609 shares of the company's stock, valued at $2,349,837.91. This trade represents a 49.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 211,894 shares of company stock worth $14,089,370. 11.10% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

RYAN has been the subject of several research reports. Wells Fargo & Company decreased their price objective on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a research note on Thursday. Barclays decreased their target price on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a research report on Friday. Keefe, Bruyette & Woods reduced their price objective on Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a research note on Wednesday, April 9th. TD Cowen began coverage on Ryan Specialty in a research note on Thursday. They issued a "buy" rating and a $89.00 target price on the stock. Finally, Royal Bank of Canada reduced their price target on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a research report on Friday, February 21st. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and seven have given a buy rating to the stock. According to MarketBeat, Ryan Specialty currently has a consensus rating of "Hold" and an average target price of $75.67.

Ryan Specialty Price Performance

Ryan Specialty stock traded up $0.96 during trading on Monday, reaching $73.77. The company had a trading volume of 293,462 shares, compared to its average volume of 939,537. The firm has a market capitalization of $19.32 billion, a PE ratio of 106.91, a price-to-earnings-growth ratio of 1.19 and a beta of 0.66. The firm's 50-day simple moving average is $70.05 and its 200 day simple moving average is $68.88. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. Ryan Specialty Holdings, Inc. has a 1-year low of $48.48 and a 1-year high of $77.16.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.02). Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The company had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million. As a group, equities research analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th were given a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 0.65%. The ex-dividend date of this dividend was Tuesday, March 4th. This is an increase from Ryan Specialty's previous quarterly dividend of $0.11. Ryan Specialty's dividend payout ratio (DPR) is 69.57%.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.